The A-HIRATE Trial was a multicenter, prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT. The trial was ...

The A-HIRATE in Pacemaker Patients Trial was designed to identify and compare the incidence of AT in patients with and without prior diagnosed AT and a standard indication for dual chamber pacing.

PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ...

MINNEAPOLIS and SAN FRANCISCO - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing feature exclusive to ...

Pacemaker stimulation via a sterile external connector produced P waves of the left atrial type, with an excitation threshold of 1.5 ma.

Through new implant-to-implant technology, this pacemaker overcomes engineering challenges by offering beat-to-beat communication between the two leadless pacemakers in both chambers of the heart.

The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...

Outcomes against which the relative effectiveness of dual‑chamber and single‑chamber pacing were assessed included the incidence of pacemaker syndrome, exercise capacity, functional status, quality of ...

A doctor at one Lowcountry hospital became the first heart specialist in the Carolinas to implant a new type of leadless pacemaker this week.